Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 162 results found. Search for [ Sun-Ranbaxy deal ]

Results 1 to 21 of 162
Nevin John
September 2, 2020
Competition Commission of India is expected to look into the overlap of retail assets and businesses in common localities belonging to Reliance and Future Group


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


PTI
New Delhi, April 11, 2019
Abhay Gandhi is CEO of Sun Pharma's North America business; Gandhi and his wife traded in Ranbaxy shares soon after Daiichi agreed to sell Ranbaxy to Sun Pharma


PTI
April 11, 2019



PTI
April 11, 2019



BusinessToday.In
December 21, 2018
The embattled billionaires now have one month to challenge the judgementin the dispute related to sale of controlling stake in Ranbaxy Laboratories to Daiichi.


PTI
December 15, 2018
The Supreme Court ordered status quo with regard to the sale of controlling stakes of Fortis Healthcare to Malaysian IHH Healthcare Berhad by former Ranbaxy promoters


BusinessToday.In
December 4, 2018
Shares of Sun Pharmaceutical Industries rose over 2 per cent in early trade on the Bombay Stock Exchange after the drug maker clarified that it has not been involved in any insider trading norm violations relating to the Ranbaxy deal.


Rajeev Dubey & Joe C Mathew
New Delhi, August 20, 2018
How Malvinder and Shivinder Singh blew Rs 22,500 crore in less than a decade and lost control over Fortis Healthcare and Religare Enterprises.


BusinessToday.In
August 11, 2018
The Delhi High Court has also asked the former promoters of Fortis Healthcare Limited, popularly known as the Singh brothers, to disclose all their transactions, including gifts, since 2016.


PTI
May 27, 2018



Gina Krishnan
New Delhi, February 6, 2018
With the Delhi High Court's verdict, Daiichi Sankyo has scored a victory against former Ranbaxy promoters. But it won't end there.


PTI
January 5, 2018



BT Online
November 21, 2017
Ahmedabad-based Eris Lifesciences' acquisition of the India brand business of Bengaluru-based Strides Shasun has been in the news.


PB Jayakumar
November 6, 2017
The Rs 3600 crore acquisition of Unichem's domestic business by Torrent Pharma has brought the mojo back into India pharma's merger and acquisition scene, which was eluding large deals in the past few years.


Mail Today Bureau
November 4, 2017
Unichem's business under consideration comprises a portfolio of over 120 products, manufacturing plant at Sikkim catering to these two markets and all the employees engaged in it, Torrent Pharmaceuticals said in a filing to the BSE.


Mail Today Bureau
November 4, 2017
Unichem's business under consideration comprises a portfolio of over 120 products, manufacturing plant at Sikkim catering to these two markets and all the employees engaged in it, Torrent Pharmaceuticals said in a filing to the BSE.


PTI
New Delhi, November 3, 2017
Unichem's business under consideration comprises a portfolio of over 120 products, manufacturing plant at Sikkim catering to these two markets and all the employees engaged in it.


by E Kumar Sharma
Delhi, January 21, 2017
Top pharma companies - Driven by inorganic growth opportunities - are also learning to live with more debt.


E Kumar Sharma
New Delhi, January 18, 2017
Its misadventure in India had began in June 2008 with the acquisition of Ranbaxy in an over $4-billion deal (around Rs 20,000 crore then) with the promise of utilising Ranbaxy's resources to become a 'global pharma innovator'.


PAGES 1 OF 9  12345